GRAL · NASDAQ · STOCK
GRAIL (GRAL) Stock Analysis
$137.14
52W $41.50 – $166.48
61/100
$6.02B
-14.4
3.25
Is GRAL Bullish or Bearish?
Bullish.
Innellis AI committee rates GRAIL Inc. (GRAL) Buy with a composite score of 61/100
, based on 6 analysts with 83% agreement.
Last updated October 14, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +14.07 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -5.93 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Supporting evidence favours the bullish case. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- Price-to-book of 1.3x is a discount to asset value — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
- ROE of only -15.9% -- cheap may mean cheap for a reason — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Weekly RSI at 88 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 73.7% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 14, 2026
Overall Committee Score
61/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 27%
of 192 Healthcare peers
Value Analyst
bullish
60
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ Price-to-book of 1.3x is a discount to asset value
− ROE of only -15.9% -- cheap may mean cheap for a reason
Growth Analyst
bullish
60
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
neutral
58
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
− Bollinger bandwidth of 73.7% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
35
/ 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score moved marginally from 63.4 to 60.9.
- New bearish signals: 2 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- Bearish pressure eased: 3 signal(s) disappeared.
Analyst-level changes:
- Macro Analyst: score 80->65 (-15).
- Portfolio Manager: score 30->35 (+5).
- Risk Analyst: +1 bearish signal(s).
- Technical Analyst: +1 bearish signal(s).
Comparing 2026-10-13 to 2026-10-14 (1 day apart).
Technical Analysis
RSI (14)
61.1
Neutral
MACD Histogram
-0.846
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.66
Inside Bands
Price vs Moving Averages
EMA 9
$136.95
Above
EMA 21
$125.21
Above
EMA 50
$104.81
Above
EMA 200
$78.64
Above
Fundamental Analysis
Valuation
95
Growth
69
Profitability
0
Financial Health
100
Cash Flow
15
Valuation
P/E Ratio
-14.4×
P/B Ratio
2.38×
PEG Ratio
-0.46
Dividend Yield
0.00%
52W High
$166.48
52W Low
$41.50
Quality & Growth
ROE
-1584.1%
ROA
-1397.5%
Gross Margin
-1082.8%
Operating Margin
-33840.0%
Revenue Growth YoY
—
Debt / Equity
0.04
AI Fundamental Assessment
P/E ratio of -14.4 (inexpensive relative to a 15-40x range); Price-to-book of 2.4x; PEG ratio of -0.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -15.8%; Return on assets of -14.0%; Net margin of -236.9%; Gross margin of -10.8%; Current ratio of 10.95 (healthy short-term liquidity); Debt-to-equity of 0.04; Free cash flow per share is negative (-6.85); Most recent quarter beat estimates by 5.4%; 4 consecutive earnings beats; EPS growth decelerating (+6.1% -> -11.8% QoQ); Analyst estimates rising over recent quarters
Get the Full GRAL Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →